Radiomics: A review of current applications and possibilities in the assessment of tumor microenvironment - 05/03/23
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | With the development of immunotherapy, assessment of the tumor microenvironment in individualized immunotherapy is becoming increasingly important. |
• | Radiomics, as an accurate imaging biomarker, can be used for non-invasive assessment of the tumor microenvironment. |
• | Despite the promise radiomics shows in the assessment of the tumor microenvironment, there are still many limitations before it can become a clinically recognized method. |
Abstract |
With the recent success in the application of immunotherapy for treating various advanced cancers, the tumor microenvironment has rapidly become an important field of research. The tumor microenvironment is complex and its characteristics strongly influence disease biology and potentially responses to systemic therapy. Accurate preoperative assessment of tumor microenvironment is of great significance for the formulation of an immunotherapy strategy and evaluation of patient prognosis. As a research hotspot in medical image analysis technology, radiomics has been applied in the auxiliary diagnosis of the tumor microenvironment. This article reviews the current status of radiomics in the elective application on tumor microenvironment and discusses potential prospects.
Le texte complet de cet article est disponible en PDF.Keywords : Radiomics, Tumor microenvironment, Tumor-infiltrating lymphocytes, Tumor-associated macrophages, Tumor-stromal ratio
Abbreviations : AUC, CPS, CT, HCC, HNSCC, MDSCs, MRI, NSCLC, PDAC, PD-1, PD-L1, PET, TAMs, TME, TIL, TPS, TSR
Plan
Vol 104 - N° 3
P. 113-122 - mars 2023 Retour au numéro
Article précédent
- Deep pelvic infiltrating endometriosis: MRI consensus lexicon and compartment-based approach from the ENDOVALIRM group
- Pascal Rousset, Marie Florin, Nishat Bharwani, Cyril Touboul, Michèle Monroc, François Golfier, Stéphanie Nougaret, Isabelle Thomassin-Naggara, ENDOVALIRM Group
- Improving pain control during transarterial chemoembolization for hepatocellular carcinoma performed under local anesthesia with multimodal analgesia
- Quentin Vanderbecq, Jules Grégory, Jeremy Dana, Marco Dioguardi Burgio, Lorenzo Garzelli, Lucas Raynaud, Sébastien Frémy, Luisa Paulatto, Mohamed Bouattour, Juliette Kavafyan-Lasserre, Valérie Vilgrain, Maxime Ronot
Bienvenue sur EM-consulte, la référence des professionnels de santé.